5 Result(s)

Article

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication

Yu-Jia Huo, Peng-Peng Xu, Di Fu, Hong-Mei Yi, Yao-Hui Huang… in Blood Cancer Journal (2022)

Article

A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes

Long noncoding RNAs (lncRNAs) play an essential role in tumor progression. Few researches focused on the clinical and biological relevance of lncRNAs in peripheral T cell lymphoma (PTCL). In this research, a n...

** Zhao, Meng-Meng Ji, Ying Fang, **ao Li, Hong-Mei Yi… in Cell Death & Disease (2021)

Article

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis

Epigenetic alterations play an important role in tumor progression of diffuse large B-cell lymphoma (DLBCL). However, the biological relevance of epigenetic gene mutations on tumor microenvironment remains to ...

Yao-Hui Huang, Kun Cai, Peng-Peng Xu, Li Wang… in Signal Transduction and Targeted Therapy (2021)

Article

CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial

Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP)/CHOP-like chemotherapy is widely used in peripheral T cell lymphoma (PTCL). Here we conducted a phase 2, multicenter, randomized, controlled ...

Ming-Ci Cai, Shu Cheng, **n Wang, Jian-Da Hu, Yong-** Song… in Genome Medicine (2020)